Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Antitumor activity of potent pyruvate dehydrogenase kinase 4 inhibitors from plants in pancreatic cancer.

Tambe Y, Terado T, Kim CJ, Mukaisho KI, Yoshida S, Sugihara H, Tanaka H, Chida J, Kido H, Yamaji K, Yamamoto T, Nakano H, Omura S, Inoue H.

Mol Carcinog. 2019 Oct;58(10):1726-1737. doi: 10.1002/mc.23045. Epub 2019 May 20.

PMID:
31106493
2.

Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness.

Kim CJ, Terado T, Tambe Y, Mukaisho KI, Sugihara H, Kawauchi A, Inoue H.

Int J Oncol. 2018 Jan;52(1):231-240. doi: 10.3892/ijo.2017.4194. Epub 2017 Nov 7.

PMID:
29115414
3.

Evolutionary analysis of two complement C4 genes: Ancient duplication and conservation during jawed vertebrate evolution.

Nonaka MI, Terado T, Kimura H, Nonaka M.

Dev Comp Immunol. 2017 Mar;68:1-11. doi: 10.1016/j.dci.2016.11.009. Epub 2016 Nov 10.

PMID:
27840295
4.

Molecular mechanisms of ginsenoside Rp1-mediated growth arrest and apoptosis.

Kumar A, Kumar M, Park TY, Park MH, Takemoto T, Terado T, Kitano M, Kimura H.

Int J Mol Med. 2009 Sep;24(3):381-6.

PMID:
19639231
5.

Anticancer and radioprotective potentials of Mentha piperita.

Kumar A, Samarth RM, Yasmeen S, Sharma A, Sugahara T, Terado T, Kimura H.

Biofactors. 2004;22(1-4):87-91. No abstract available.

PMID:
15630259
6.

Molecular cloning of C4 gene and identification of the class III complement region in the shark MHC.

Terado T, Okamura K, Ohta Y, Shin DH, Smith SL, Hashimoto K, Takemoto T, Nonaka MI, Kimura H, Flajnik MF, Nonaka M.

J Immunol. 2003 Sep 1;171(5):2461-6.

7.

Conservation of the modular structure of complement factor I through vertebrate evolution.

Terado T, Nonaka MI, Nonaka M, Kimura H.

Dev Comp Immunol. 2002 Jun;26(5):403-13.

PMID:
11906721
8.

Occurrence of structural specialization of the serine protease domain of complement factor B at the emergence of jawed vertebrates and adaptive immunity.

Terado T, Smith SL, Nakanishi T, Nonaka MI, Kimura H, Nonaka M.

Immunogenetics. 2001 Apr;53(3):250-4. No abstract available.

PMID:
11398970
9.

A detailed linkage map of medaka, Oryzias latipes: comparative genomics and genome evolution.

Naruse K, Fukamachi S, Mitani H, Kondo M, Matsuoka T, Kondo S, Hanamura N, Morita Y, Hasegawa K, Nishigaki R, Shimada A, Wada H, Kusakabe T, Suzuki N, Kinoshita M, Kanamori A, Terado T, Kimura H, Nonaka M, Shima A.

Genetics. 2000 Apr;154(4):1773-84.

10.

Neocarzinostatin-induced mutations at the hprt locus in exponentially growing CHO cells, compared with spontaneous mutations.

Kimura H, Takada T, Shingu Y, Kato Y, Iyehara-Ogawa H, Terado T.

Carcinogenesis. 1998 May;19(5):791-6.

PMID:
9635864
11.
12.

Immuno-localization of H+/peptide cotransporter in rat digestive tract.

Ogihara H, Saito H, Shin BC, Terado T, Takenoshita S, Nagamachi Y, Inui K, Takata K.

Biochem Biophys Res Commun. 1996 Mar 27;220(3):848-52.

PMID:
8607854
13.
15.
16.

[Isolation of urinary heparan sulfate and chondroitin sulfate and their inhibitory activity of calcium oxalate crystal growth].

Iwata H, Terado T, Kin M, Nishio S, Matsumoto A, Takeuchi M.

Nihon Hinyokika Gakkai Zasshi. 1991 Mar;82(3):405-11. Japanese.

17.

[A comparative clinical trial of UFT medication and intravesical BCG in the recurrence of superficial bladder cancer. Study Group of UFT and BCG adjuvant therapy for bladder cancer].

Oda H, Seki N, Nabeshima S, Oda T, Nishio S, Yokoyama M, Iwata H, Takeuchi M, Matsumoto A, Terado T, et al.

Gan To Kagaku Ryoho. 1990 Oct;17(10):2051-5. Japanese.

PMID:
2221929
18.

[Inhibitory factors of calcium oxalate crystal growth in urinary macromolecules].

Matsumoto A, Terado T, Kin M, Nishio S, Iwata H, Takeuchi M.

Nihon Hinyokika Gakkai Zasshi. 1990 Jun;81(6):883-8. Japanese.

Supplemental Content

Loading ...
Support Center